Latest / The MaineHealth Podcast / Curbside Consult: Hypertension Treatment with Dr. Christopher Tuohy
Transcript
- 0:05From the MaineHealth ACO, this is Curbside Consult, the podcast that brings
- 0:09together specialists and primary care providers for informal clinical discussions. I'm Mike Clark.
- 0:16And I'm Heather Ward. Mike and I are family physicians and participants in the MaineHealth ACO.
- 0:22Today, we are digging into the topic of hypertension control with Dr. Christopher Tuohy.
- 0:28Chris is a board-certified interventional cardiologist with MaineHealth Cardiology.
- 0:33He studied medicine at Penn State and public health at Rutgers and has dedicated
- 0:39his career to improving cardiovascular health here in Maine. Chris, welcome.
- 0:46Thank you. Thank you for having me.
- 0:49I'm wondering, even though I think most of the people listening to this are
- 0:53going to be providers, they're going to have a base knowledge of hypertension, just to
- 0:58put it out there, I'm wondering if we could talk about how we define hypertension,
- 1:03especially for this conversation, and maybe even get into how different societies
- 1:07might define hypertension,
- 1:09lead us into some of the conversation about potential controversy and treatments.
- 1:14Yeah, absolutely. So, you know, I think this is a really exciting time and topic
- 1:19to be talking about because there's a lot going on with this.
- 1:22And, you know, you look at hypertension, it's, you know, probably the most prevalent
- 1:27modifiable risk factor for cardiovascular disease.
- 1:31And it's extraordinarily prevalent in society. I mean, almost half of people
- 1:35in the U.S. have a diagnosis of hypertension. I think it's like 120 million people.
- 1:39And we know that the risk of hypertension and cardiovascular disease is directly related,
- 1:45and a 20 millimeter of mercury systolic blood pressure reduction or a 10 millimeter
- 1:50of mercury diastolic blood pressure reduction halves people's risk of cardiovascular disease.
- 1:54So from the interventional side of things, my goal is to fix those people when
- 1:58they're there, but I'd really love it if it just never happened to them in the
- 2:01first place. And so addressing these issues is saving lives in the long run,
- 2:06a lot more lives, and that's amazing.
- 2:09So yeah, when we're talking about hypertension, the first thing we need is to
- 2:12define our terms and what does it mean?
- 2:14What is hypertension? So you can start off very recently, 2025,
- 2:18the ACC and AHA came out with their updated guidelines for hypertension,
- 2:22first updated since 2017.
- 2:25And their definition, so normal blood pressure would be less than 120 over 80.
- 2:30Anyone who has a systolic blood pressure in the 120s with a diastolic still
- 2:34under 80 is elevated blood pressure.
- 2:37And then anyone who has a blood pressure a systolic greater than 130 or diastolic
- 2:42greater than 80 is stage one hypertension.
- 2:46And anybody with a systolic over 140 or diastolic over 90, either or, is stage two.
- 2:52There's, you know, other guidelines you can look at, like the ESC,
- 2:55ESH, or the family medicine guidelines still keep that little bit of a looser
- 3:00definition of 140 over 90 as being the cutoff.
- 3:03But the AHA and ACC kind of, you know, redefined it a bit, but also staged things.
- 3:09And that will have some relevance in terms of, you know, what the recommendations
- 3:12are in management of these patients.
- 3:16That's really helpful. You know, I'll just throw it out there right now.
- 3:19Maybe we can get back to it later.
- 3:22For the main health ACO or quality metrics, we have hypertension metric that's on there.
- 3:28And I would say that uses more of the looser recommendation or target of less than 140 over 90.
- 3:39And honestly, like we're struggling to get there.
- 3:42Right. Like we don't have good performance on that right now.
- 3:47And so I'd be curious to hear from you, how do you recommend being aggressive
- 3:54or less aggressive with treating blood pressure?
- 3:58Yeah. Well, you know, with any clinical interaction, right, you take each patient,
- 4:02although we talk about them broadly in these terms, they're all unique.
- 4:05Yeah. And, you know, there are all of their unique factors going on that can
- 4:09weigh into how we manage them.
- 4:11But, you know, there's a spectrum sort of what you're thinking about.
- 4:14And there's those individuals who you're going to want to really be as aggressive
- 4:18as you possibly can in managing their blood pressures.
- 4:21And then there's those scenarios where, you know, you might want to think about being a little looser.
- 4:25For me, you know, I'm looking at long term risk. So if I've got that young patient,
- 4:30you know, who's got, you know, risk factors, who's got a strong family history
- 4:34of early onset coronary disease or early onset stroke, you know,
- 4:37and they're otherwise healthy and can tolerate medications.
- 4:41And you're looking at a really long term, decades and decades and decades long,
- 4:45you know, management of their blood pressure and that cumulative risk that'll occur.
- 4:49You know, those people are ones that I'm going to want to really try to be aggressive
- 4:53because, you know, and a lot of the impetus for the guidelines and recommending.
- 4:57Lower, you know, target goals, some of them, is that a lot of the data that's
- 5:01been coming back in from all these, you know,
- 5:04many clinical trials and meta-analyses of all these data that has been looked at,
- 5:08do show that there is evidence of risk of increased cardiovascular disease,
- 5:11even at lower blood pressures, even from an increase of 115 to 125 systolic,
- 5:17that you are going to have
- 5:19increased risk of cardiovascular disease from that. So that seems to be the reality.
- 5:24And so there is, there is, you know, support behind trying to aim for these
- 5:28lower goals, but, you know, something that happens in a clinical trial is not
- 5:32always equal to what happens in the clinic.
- 5:34And so we've got to deal with them, you know, is how they come.
- 5:37And so, you know, the other end of the spectrum of patients,
- 5:40you got patients that are much older and then they're going to have,
- 5:42you know, more labile blood pressures. And, you know, the last thing you want
- 5:46is to cause someone to have a low blood pressure and have a fall and a head
- 5:49strike and something like that.
- 5:52I take each person individually as they come. I look at what they're at,
- 5:55but I think they'll be able to tolerate,
- 5:57It's important to try to get to goals, but I think we should also be proud of
- 6:01our incremental improvements in things.
- 6:03Lowering someone's systolic blood pressure by five points, just five points,
- 6:07decreases their cardiovascular risk by 10%. Wow.
- 6:11So it may not feel like we're at 145 and now we're at an average of 138.
- 6:17That may not feel like much, but that's huge. You've made a big difference.
- 6:22That's actually super encouraging. And I appreciate that, that you coming from
- 6:27that perspective of that individual patient that, you know, we talk in terms
- 6:31of populations and population health is huge and we've got to keep our eye on that ball.
- 6:35But we do it one patient at a time and in the context of their individual situation.
- 6:41So I so appreciate you validating that starting point as a primary care doc.
- 6:48I, you know, I sometimes struggle with even just being sure I've actually made
- 6:52the diagnosis. You know, we got the white coat hypertension issue.
- 6:54We have, you know, we fortunately have the opportunity to see patients serially,
- 7:00and maybe bring them back or have them come back for a blood pressure check.
- 7:04What are some of the things to keep in mind? If you could pretend you were a
- 7:07primary care doc for a minute with us, step,
- 7:10into our clinic And if you're seeing a patient maybe for another reason and
- 7:14their blood pressure is high, what are some of the things that you would want
- 7:16to have in place to really secure that diagnosis and assign that diagnosis,
- 7:20including maybe initial tests?
- 7:22Yep, absolutely. So a challenge, right? The first thing in treating any disease
- 7:27is you want to make sure you've got the right diagnosis.
- 7:29And there's lots of barriers to doing that in hypertension. I think that that
- 7:33has gotten better for some reasons, new tools that we have, which we can talk about.
- 7:38But, you know, in terms of, you know, measuring, you know, measuring a patient's
- 7:42blood pressure in the office, when you want to establish that,
- 7:45you know, there's, there's, there's,
- 7:47you know, a right way to do it, which is really hard to do in a busy office
- 7:53when you're seeing lots of patients.
- 7:55And so, you know, to go through those things, you know, now the recommendation
- 7:58is we want to be using an automated blood pressure cuff and oscillometric device,
- 8:04but not use, you know, the old stethoscope and blood pressure cuff and a nanoroid device.
- 8:08And for both in-office and patients at home, which we'll talk about a little
- 8:12bit, not all the devices are the same.
- 8:16There is a lot of these devices, actually, some of them go through a strict
- 8:19validation process to make sure that they work and others don't.
- 8:23You can actually access that information very easily at validatebp.org.
- 8:28You can look up the cuff and, you know, when you're looking at your patients
- 8:31in the office and they ask what we should use, you can give them a list of things that they can get.
- 8:36So we want to be using an automated cuff. We want to make sure that the patient
- 8:39hasn't just smoked a cigarette, hasn't just drank a stiff cup of coffee as an
- 8:44exercise in the last 30 minutes,
- 8:46that the cuff size is correct, that the arm is bare and there's not a thick
- 8:50sweatshirt on that you're putting it around.
- 8:53You want the arm supported at that level of the heart, feet on the ground,
- 8:57at rest for five minutes, sitting in a chair.
- 9:00And then you want to try to get two readings at least one minute apart,
- 9:05take the average of the two, and that's your blood pressure. Now that's hard to do.
- 9:09And so I think it's, you know, pretty rough to try to make sure that every single
- 9:13one of those boxes is perfectly checked like they do in the clinical trials in everyday practice.
- 9:18But, you know, it doesn't mean that we can't make some improvements,
- 9:21you know, that we can try to, you know, incorporate as many of those things
- 9:24as we possibly can to try to have that office blood pressure as accurate as we possibly can.
- 9:29But we're still going to run into lots of trouble, as we always had.
- 9:32Some people are going to have white coat syndrome, and they're going to have
- 9:34this really high blood pressure in the office, and you're going to start them
- 9:37on something, and then they're going to call you in a week and tell you how
- 9:39dizzy they are because their blood pressure is low.
- 9:41And so even with that, the office is still a challenge. And so I think now having.
- 9:47The access to home-based blood pressure monitoring and ambulatory blood pressure
- 9:50monitoring is a huge help.
- 9:52It has been validated in numerous studies and shown to be more accurate in the
- 9:56office-based measure, and we hopefully can do that in a lot of our patients.
- 10:00So, you know, as far as that goes, you know, making sure that the patient as
- 10:04best you can has one of the validated automated cuffs at home.
- 10:08And then, you know, you want them to ideally, you know, the best way for me
- 10:12when I see these patients in the office, I like to have a really good sense
- 10:15of what their blood pressure has been for the last week.
- 10:18And so I say, you know, track it as best you can over time.
- 10:21And that goes on going forward as you're titrating medicines.
- 10:24But, you know, in the week leading up, if it's possible for them to do,
- 10:28to try to get me, you know, two readings in the morning when you wake up after
- 10:32they've gone to the bathroom and emptied their bladder a minute apart,
- 10:35two readings at night before they go to bed, average the two,
- 10:38write it down in a little notebook and bring it with you when you see me is what I'll tell them.
- 10:42If they can do that for seven days straight, that's great. but even,
- 10:44you know, they can do it four out of seven days. That's still really helpful
- 10:48in terms of, you know, really making that diagnosis.
- 10:51But in the end, it's, you know, you're going to be doing the best you can.
- 10:53But as many of things like that, that you can do to make sure that both your diagnosis is accurate.
- 10:58And then as you're, you know, ongoing and following them longitudinally,
- 11:02that you're having a good sense of where things are going as you're implementing therapies.
- 11:06You mentioned the question in terms of, you know, an initial workup for patients.
- 11:10So, you know, when we've made that diagnosis of hypertension,
- 11:14you know, by one mechanism or another, and we're making that diagnosis newly
- 11:18in a patient, there are a handful of things that you do want to check right off the bat.
- 11:23So all those patients in terms of blood work should get a CBC,
- 11:26a BMP, a lipid panel, a hemoglobin A1C, a TSH.
- 11:32A urinalysis, a urine albumin creatinine ratio, which is a new recommendation
- 11:37in the guidelines in 2025, and an ECG just to get a sense of if there's any
- 11:42evidence of left ventricular hypertrophy,
- 11:44or downstream effects of longstanding not well-treated hypertension. That's great.
- 11:50I think as a busy primary care provider, being reminded of all the other stuff
- 11:57to get on that initial diagnosis is really, really important.
- 12:05I want to circle back to something that you said, and this is my own thing.
- 12:08I'm wondering about the smoking cigarettes. So.
- 12:16Why would we not treat somebody who has elevated blood pressure when they come
- 12:22in, if they've smoked recently, if they're just smoking all day long, right?
- 12:26Like, wouldn't we want to bring their blood pressure down to a more reasonable
- 12:30level, knowing that they're going to keep smoking? Unless we can get them to quit, which is amazing.
- 12:37But, you know, maybe we need to treat their blood pressure while we're working
- 12:40on that. Like, what do you think about that?
- 12:43Or maybe how do you personally approach that? Is that something that you really,
- 12:47truly adjust for, or do you just treat them?
- 12:52No, that's such a great question. You know, I think, you know,
- 12:56that's true of a lot of things. I think, you know, there's a general principle,
- 12:59you have to treat patients as they are.
- 13:01But there are, you know, a number of modifiable risk factors that can change
- 13:05over time that will, you know, if they do them, change their blood pressure,
- 13:09hopefully in the right direction.
- 13:10So smoking, quitting smoking, absolutely. You know, alcohol consumption and
- 13:15limiting alcohol use may help on its own decrease their blood pressure. Losing weight.
- 13:20We know for every one kilogram of weight loss, that decreases systolic blood
- 13:27pressure by about one. So one point for every kilogram.
- 13:31Maybe they're on other medications that are increasing or supplements that are
- 13:35increasing their blood pressure, and they're going to stop those.
- 13:38So I think the goal is to have their blood pressure well-controlled.
- 13:43We can talk a little bit about the intricacies of management,
- 13:45and it may change depending upon how bad it is, you know, and certainly someone
- 13:49who's actively smoking, but their blood pressure is 160 over 95.
- 13:53Well, you know, pretty easy. We're going to treat your blood pressure,
- 13:55but you know, for someone who's on the lower end, you know, that's where the
- 13:59longitudinal monitoring their blood pressure at home and following those readings,
- 14:03you know, those things can change over time.
- 14:05And we want to be able to be ready to react to that and back off of meds,
- 14:10which is the patient's favorite phone call to get.
- 14:13I'm down the road. But I think, yeah, you have to treat people as they are.
- 14:20You don't know what the future is going to hold in that moment in time.
- 14:23I mean, you don't want them to be going a year with poorly controlled blood
- 14:26pressure because we were sort of waiting for things to happen that were never going to happen.
- 14:30But we do want to be ready to respond to them in the hopes that they do,
- 14:34that the patients do make those lifestyle modifications and improve things. Yeah.
- 14:39Well, I agree with you. I think being able to reward them by saying,
- 14:42like, oh, you quit smoking and you quit drinking. Now look, your blood pressure
- 14:45is low. Let's take you off this medication. That's fantastic.
- 14:50I would love to hear what your approach is with treatment and how,
- 14:57maybe how aggressive you are with making adjustments.
- 15:02And I don't know if I'm jumping ahead, if maybe we should step back and say
- 15:06like, okay, like, what is your treatment approach? Maybe we start there.
- 15:12My i'm coming from it thinking even in my own practice like in my own office,
- 15:20i see patients who every time they come in they're one let's just say 140 over 90 145 over 92
- 15:26every single time and and no change no meds started no changes like sort of
- 15:32the assumption oh they just raced in or there was an accident or there they
- 15:35went up or they did that and then and it's a year,
- 15:39and they're sitting around with a blood pressure potentially 140 over 90 for
- 15:43a year and we could have been managing it and,
- 15:49so i guess my first question is when do you make that decision to start a medication
- 15:54and then what are you choosing and and how are you making that choice yeah absolutely
- 16:01yeah a lot there you know i think.
- 16:04In broad terms, as we're making decisions, you know, what to do with medication management,
- 16:08a big part of that, you know, we're going to be as good as the data we're getting,
- 16:12from the patient, you know, and if we are able to do a really good job and have
- 16:17a really good sense of what their blood pressure is doing over time at home
- 16:21and reliable numbers, we're going to be able to do such a better job managing
- 16:24their blood pressure than if we're sort of out there in the dark,
- 16:27which is where we find ourselves so many times.
- 16:29You know, you got one reading, I got one office reading, God,
- 16:32I don't want to overshoot it, but I don't want to miss anything,
- 16:34you know, and that's tough, right? And that's reality.
- 16:36This is where working in, in general, as best we can, you know,
- 16:40a team-based approach to these patients and, you know, getting them in programs
- 16:46like I know that we have at Mean Health where, you know.
- 16:50With pharmacists and nurse practitioners and others where they're getting,
- 16:53you know, a lot of communication over a short period of time.
- 16:55That's the ideal world and and really emphasizing to these patients,
- 16:59you know, to be getting their home blood pressure monitoring and updating with
- 17:04those numbers and using things like my chart, you know, that's what I have patients do all the time.
- 17:08I said, just, you know, take it, send it in. And some of them are so great about that.
- 17:12That just makes life so much easier in terms of managing them.
- 17:15So you're only going to be as good as the data that you're getting in and how
- 17:18well you're following things.
- 17:19But, you know, for me in general, you know, bearing in mind the uniqueness of patients.
- 17:24But when I'm approaching these patients, one thing that has changed,
- 17:28I think, for me, with patients who have obviously no hypertension.
- 17:34You can recommend lifestyle modifications because those things are all great no matter what you do.
- 17:37For those patients that have stage one hypertension, so we're talking about
- 17:42135 over 82 in the office or 139 over whatever,
- 17:48if they have nothing else going on, I will send them out with lifestyle modifications
- 17:53and all that and see them back in three to six months and try to get a good
- 17:57sense of their blood pressures over time.
- 17:59But the big trigger for me is risk factors. When I hear that,
- 18:03you know, if they have themselves already a history of cardiovascular disease,
- 18:08I'm not going to wait for those patients. I'm going to get on starting initiating a therapy for them.
- 18:12And for someone who's in that stage one, it's probably just going to be a single
- 18:16agent, you know, low dose and see how it goes.
- 18:19For people who don't have already themselves have a history of that,
- 18:22but, you know, they've got diabetes, maybe they've got chronic kidney disease,
- 18:25they have a very strong family history of early onset cardiovascular disease.
- 18:29They're smoking. They have all those other things.
- 18:31And those people, I will probably just jump to starting them on something,
- 18:36some motor, single agent, just to get the ball rolling because I don't want to waste any time.
- 18:41And then one other tool that you can use in the office, the ACCA guidelines
- 18:46have this new prevent calculator, which is an update to the ASCVD risk calculator that we used to use.
- 18:52Still comes out with kind of similar data. You get a percentage of risk of cardiovascular
- 18:57disease, and their recommendation is if it's greater than 7.5%,
- 19:01you know, go ahead and start a med.
- 19:03So you can use that for what it's worth. But for me, it's just assessing how
- 19:06worried am I about this patient and kind of where they're at.
- 19:10For those who have stage 2 hypertension, for the most part, those people.
- 19:14If I can, starting them on two agents, two low-dose agents, trying to do that
- 19:19a combination pill if possible.
- 19:21What's so great now is we have developed all these incredible new drugs for treating.
- 19:28For a long time, the problem was affordability. But now almost all of these
- 19:32medications are generic.
- 19:35They're on the $4 list. They're cheap for patients, which is really,
- 19:39really, really super helpful.
- 19:41So my first reach was probably a good time to mention, And so,
- 19:46what medications and classes should you be thinking of, you know, thiazide diuretics,
- 19:53long-acting calcium channel blockers, ASARB. That's your first line.
- 19:57Any one of those three or two in combination.
- 20:00I personally will try to start patients on a combination pill of omosartan and hydrochlorothiazide.
- 20:06I feel like we still have so many patients that are still on losartan and some
- 20:10of the old ARBs, which is fine, but the newer meds are better.
- 20:16The omosartans of the world and the vasartans of the world, these are longer-acting
- 20:19medications, so you're going to get better coverage throughout the course of the day.
- 20:23And they have better effect on blood pressure than Losartan does.
- 20:26And most are all generic now.
- 20:29So, you know, that double single agent combination pill, you know,
- 20:32and one single pill to, you know, improve compliance with the patients is what I'm going to reach to.
- 20:38And, you know, you might ask, well, you know, why, why wouldn't we just do the
- 20:42one med and just kind of update right that one med so they don't end up on two.
- 20:46And the reason for that for me is, you know, if you can do it in a single pill,
- 20:50it's still only one pill for them.
- 20:52At the lower doses of these medications, you're going to have less side effects in patients.
- 20:57And two agents acting on two different pathways is going to do a better job
- 21:02at low doses than, you know, the up titrated dose of the single pill.
- 21:06You know, the rate of side effects in these patients is pretty linear related
- 21:10usually to the dose of the medicine. And so if you're thinking about compliance,
- 21:14you know, and all the things we see every day, when you start the meta,
- 21:17then they call back and they say, no, I had this side effect. I can't do it.
- 21:20And if you can do it with a single pill, two low doses, you're going to have
- 21:23less side effects, more compliance and get better results.
- 21:27That's perfect. That makes so much sense. And like you said,
- 21:32patients sometimes balk at two meds over one and being able to have that conversation,
- 21:37just as you stated, is really helpful.
- 21:38That makes a lot of sense. And I think, I know as a primary care,
- 21:42sometimes you get to, you know, your third drug.
- 21:44So that, you know, we have those four classes of which you choose three because
- 21:48you don't combine ACEs and ARBs. But going to the fourth drug was always a question,
- 21:54which I think is a little bit clearer now.
- 21:56Is there some agreement on what the fourth drug is once you exit that first
- 22:01tier? Yeah, there is some agreement on that now, finally.
- 22:06The recommendation would be for a mineralocorticoid receptor antagonist like
- 22:09spironolactone. But then after that is where it gets murky.
- 22:16Yeah, can you help us in that? Can we wander into that dark space for a minute or two? Absolutely.
- 22:21Yeah. So, you know, for me, that's what I'll reach to first.
- 22:24If I'm at that point, I've got them on the three other agents and whatever maximum
- 22:28doses of those they can tolerate from a side effect profile,
- 22:31you know, I will reach to mineralocorticoid receptor antagonists as the next.
- 22:35After that, you know, I don't have a particular preference after that.
- 22:39After that, what I usually am looking at is, you know, are there comorbid conditions
- 22:44that they have in which one of these classes of medications could potentially be beneficial to them?
- 22:49And for me, what always comes up, because I'm an interventional cardiologist, is beta blocker.
- 22:56So for those patients, most of them already have an indication or are already
- 23:00on a beta blocker. So that's kind of an easy one for me.
- 23:03Preferentially, in those if I can, if I'm looking for more blood pressure control,
- 23:09I will reach to Carvetalol.
- 23:11Because you'll get a little bit more blood pressure control compared to the other beta blockers.
- 23:15And then it's really, what else is going on? Is this a patient with heart failure,
- 23:20with reduced ejection fraction, Carvedolol is fine for that.
- 23:23Long-acting metoprolol is fine for that. Bisoprolol is fine for that.
- 23:27Is this someone who has atrial fibrillation and they're looking for,
- 23:30in addition to some blood pressure lowering, rate control,
- 23:33and all that kind of stuff, okay, maybe we should lean towards a shorter-acting
- 23:37metoprolol so that they can have something they They can titrate a little more
- 23:40to their heart rates at home.
- 23:42So all those, I look at the other factors and the comorbid conditions and,
- 23:47you know, if there's something else that's going to be helpful for them.
- 23:50Otherwise, you know, it's sort of just a random choice.
- 23:55Can I ask, sorry, Mike, I see you trying to jump in there. I just wanted to clarify one thing.
- 24:01Like, how fast are you making changes in medications?
- 24:05Yeah, yeah. as fast as we can, in general,
- 24:10you know, a stage one situation where the blood pressure is not really all that
- 24:14bad, they're 137, you know, over 82, that patient, you know,
- 24:18starting them on a single agent.
- 24:20It is really nice whenever you've made a change in medication,
- 24:22if you can follow up somewhere in a one-month time frame and sort of the change group.
- 24:28You know, for those patients who, you know, are sort of on the borderline and
- 24:31we're just going to try, they don't have any other risk factors,
- 24:34their prevent score is low, everything else is fine, you know,
- 24:37we'll initiate lifestyle changes. And then somewhere in the three to six month
- 24:41range for me is fine for that.
- 24:43And then at that point in time, you know, they're not at goal.
- 24:45And hopefully at that point in time, you've got some good home blood pressure
- 24:48monitoring data to have a better feel for kind of where they're at.
- 24:51And you're in a better, better position to know where they're at and whether
- 24:54or not you need to or don't need to, to start treating them.
- 24:58But I think, you know, anytime you're making changes, you know,
- 25:00ideally, if you can get some kind of one month follow-up, whether that's just
- 25:04a BP check in the office or, you know, for me, a lot of times,
- 25:08I mean, we're in Maine here.
- 25:10And so a lot of these patients are really far away and it's awfully hard for
- 25:13them to get to me for anything, any of their needs, whether that's from coronary
- 25:17disease or vascular disease or hypertension management.
- 25:20So, you know, phone calls, MyChart messages, you know, get me two weeks of data,
- 25:26get me a month of data, just send it to me and I'll give be a call. I do a lot of that.
- 25:31Nurse practitioner in the office, Joanna Neves, who's incredible.
- 25:35I can give her a little plug. She does an amazing job. And we'll talk a little
- 25:38bit later about renal denervation is really just taking that program over.
- 25:42You know, she does incredible work in a lot of those follow-ups.
- 25:45We are in constant communication many times, all day, every day,
- 25:49but really use anything at my disposal. But especially in these stage two patients,
- 25:54you know, a lot of risk factors.
- 25:56I really want to have them under control within six months. In my mind,
- 25:59it's like, if I can get them into reasonable control within six months,
- 26:02I'm happy. So what do I need to do to get there?
- 26:05That makes so much sense. I really appreciate that. It's,
- 26:09It, you know, leveraging your, even your reference to leveraging the team,
- 26:13I think that's been super important.
- 26:15Even a small primary care office using my medical assistant,
- 26:18right, has been super important.
- 26:20Bringing patients back for just a blood pressure check visit with the MA or,
- 26:24just, you know, using those, those opportunities to bring a patient back and
- 26:27keep, keep, keep pushing, right, until we get the patient to goal.
- 26:33That also, I think that signals to the patients that we're paying attention,
- 26:36right? That it matters and that this is important because they don't feel bad, right?
- 26:40And we're telling them that they have a problem and they feel fine.
- 26:44So I really appreciate that approach. And that's a good segue too.
- 26:48So we've got patients on four drugs. We're thinking about a fifth one.
- 26:52We're thinking about other, you know, maybe that we've thought through secondary
- 26:57causes, you know, we've back to that in our heads, but now we're thinking we're needing help.
- 27:03When should a primary care refer a patient with hypertension to cardiology or
- 27:09another specialty? What are your thoughts on that?
- 27:12Well, I would say as a general principle, when people call me about patients,
- 27:15I tell them you can refer them to me anytime you feel like you need help.
- 27:19So that's the bottom line. You know, when I was in training,
- 27:23I remember as a cardiology fellow, right, you get lots of pages and it's the
- 27:26middle of the night and it just seems like it's relentless.
- 27:28And I had a great mentor who told me once, every time you get into that situation
- 27:31and you're so busy and you're getting pages, remind yourself if someone's calling
- 27:34you, they're asking for help for a patient.
- 27:38And it really kind of helps you when you're in that stress and fog to,
- 27:41you know, ground yourself and remind yourself of why we do this.
- 27:44So anytime that you feel like you need help, you know, to give some guidance
- 27:48into what's most helpful for, you know, specialists for when they're seeing patients.
- 27:52So, you know, one other general principle. So we're talking about resistant
- 27:56hypertension. So when we get to that point, we're thinking about the workup
- 28:00for resistant hypertension and what things do we want to look into.
- 28:03You get a lot of that screening from your first, you know, run through your
- 28:07BMP is going to determine if they have chronic kidney disease.
- 28:10Your, you know, your urine creatinine and albumin ratio is going to get you
- 28:14to understand if there's albuminuria going on.
- 28:16You know, if there's thyroid disease, if there's those things,
- 28:20you know, other things to think of, and this is probably a good time to mention
- 28:22this because there's a bigger emphasis on now is thinking about things like
- 28:26primary hyperaldosteronism.
- 28:29There's a thought that this is probably more common in society than we think it is.
- 28:34It used to be kind of a focus on, well, if their potassium's low,
- 28:37we'll look for it, but otherwise they probably don't have it.
- 28:39It seems like that's not true.
- 28:41About 40% of patients with primary hyperaldosteronism will have a normal potassium.
- 28:47And so not a reason not to check it.
- 28:49And anyone that you're in the realm of resistant hypertension, I would check that.
- 28:54And for that, you want to get a plasma renin, a plasma aldosterone, and a ratio,
- 28:59The other big quagmire that comes up is they say, well, what medications do
- 29:02I need to hold? This is going to be complicated. Do I have to do all this and
- 29:05tell them to do that? So it's very simple now.
- 29:07They can continue every one of their blood pressure medications with the exception
- 29:11of a mineralocorticoid receptor antagonist. That is the only one that needs to be stopped.
- 29:15Continue all the other ones. We don't want any barriers to getting this information.
- 29:20So that's another one. In terms of thinking of specialists, so first and foremost,
- 29:24I say, well, if you've done an initial resistant hypertension workup and something
- 29:29has come up, they should go see that specialist.
- 29:32They've got primary hyperendosterism, they should go see an endocrinologist,
- 29:35you know, so you can think in that way.
- 29:37The other big category to think about from a vascular standpoint,
- 29:41obviously, is renal artery disease.
- 29:44So renal artery atherosclerotic stenosis and also fibromuscular dysplasia.
- 29:50For screening purposes can be done very simply with a renal artery ultrasound.
- 29:55Easy, quick test, no contrast, no radiation, and usually is pretty reliable.
- 30:00There are sometimes limitations.
- 30:02They'll comment in the study that there was a lot of bowel gas or other reasons
- 30:05why they couldn't see things well, and then, okay, fine.
- 30:08Probably just send to me at that point, and I'll look at the images,
- 30:12and I'll decide what I want to do next. But that's a great first screening test
- 30:17to have. When patients have that already, when they come to see me,
- 30:21it's great. It makes my visit so much more efficient.
- 30:24And so that's an easy one. When you are ordering that test and you're getting
- 30:28it back, it's going to use terminology. It's going to say either the renal arteries look normal.
- 30:33It's going to say there's less than 60% disease. It's going to say or there's
- 30:37greater than 60% disease.
- 30:39And it's going to give you a
- 30:40ratio of the velocity in the aorta to the velocity in the renal arteries.
- 30:45So what do we do with that? Less than 60 or greater than 60 and all that.
- 30:49So things that are consistent with significant, hemodynamically significant
- 30:54disease, the ratio is the first and most important. If that ratio is greater
- 30:58than 3.5 when you're looking at that study, that's most consistent with severe.
- 31:04Velocity greater than 200, you know, also along those lines.
- 31:07But I would, you know, from your standpoint, I would just be thinking about
- 31:10if it's greater than 60%, but the ratio is two, it may not be.
- 31:15But for fibromuscular dysplasia, you can often see those changes on the duplex
- 31:21imaging. You can see that kind of beaded appearance or something will look abnormal.
- 31:25A CT angiogram is going to be your gold standard diagnosis for that.
- 31:28Well, an invasive renal artery angiogram is going to be your gold standard,
- 31:32but not everybody's going to get that. So a CT angiogram is good to look for
- 31:36that beaded appearance.
- 31:38So, you know, for those things, like I said, you know, anytime that you feel
- 31:43that you need help, you send them.
- 31:45If they come to me and they've already had, you know, this workup,
- 31:48they've had the normal standard blood work, they've had their renin,
- 31:51you know, aldosterone and ratio checked.
- 31:54And they've got a renal artery ultrasound already done, that's best case scenario
- 31:58because then I can just, you know, be very efficient with our visit and sort
- 32:01of moving on through what to do next.
- 32:03You know, on that subject from a vascular standpoint, so for renal artery stenosis,
- 32:07stenting is what you can do to fix that.
- 32:09My threshold to do that is pretty high. I think we know from data that that
- 32:13definitely can cause resistant hypertension, but it usually only does so in specific situations.
- 32:18So when there's bilateral disease involved that is both severe or when there's
- 32:23really just an atretic kidney on one side and the only good healthy kidney is
- 32:27the one that has a severe blockage.
- 32:30That's the other scenario. In terms of things that would push you towards stenting,
- 32:36obviously resistant hypertension when present in the presence of bilateral renal artery disease,
- 32:42patients who are showing up at the hospital with flash pulmonary edema,
- 32:45cupulmonary edema recurrently, those are going to be a high trigger to think
- 32:49about fixing those patients.
- 32:51And then the other one is patients who just have progressive worsening chronic
- 32:55kidney disease with no other clear explanation with tight disease on both sides.
- 32:59Those would be what would push you more towards fixing.
- 33:02And then in the case of fibromuscular dysplasia, which is something we're just
- 33:06finding more and more of in society, I have a lot of those patients.
- 33:10The etiology of what's blocking their radial arteries is different.
- 33:13It is not atherosclerotic plaque.
- 33:16It is this weakening of their wall and their connective tissue,
- 33:19you know, causing kind of strictures almost in the vessel.
- 33:22And for those patients who have that, the answer is actually to just balloon
- 33:25it and not leave any metal or stenting behind.
- 33:29And for those patients who have resistant hypertension, NFMD involving the renal
- 33:33arteries, when you balloon them, you cure their hypertension most of the time.
- 33:38So good things to know about.
- 33:39How common is that? How common are you, I guess, how many patients a year are
- 33:47you seeing where you're doing this procedure?
- 33:51For stenting or ballooning? Yeah. Yeah. Not super commonly. You know,
- 33:55like I said, my threshold for intervention is high.
- 33:59I really do believe that there is only a specific subset of patients that are
- 34:02going to benefit from this.
- 34:04And so I am usually, you know, in the absence of some of those more scary things,
- 34:11patients who've got multiple hospital admissions for flash pulmonary edema,
- 34:15patients who've just got a declining renal function or things like that,
- 34:19you know, that are just sort of, you know, have resistant hypertension and have
- 34:23some disease in both of their renal arteries.
- 34:25I am really trying to push medical management and non-invasive management of
- 34:30those patients to the full extent that I can, that they'll allow me to.
- 34:34And it's really only in the context of where I've gone as far as I can go with that.
- 34:39The blood pressures are still very high. And that's when we'll have a kind of
- 34:43a shared decision-making conversation about, you know, risks and benefits of
- 34:47fixing it under vascularly.
- 34:50That's really helpful. Thank you.
- 34:53You had mentioned one thing I want to just probe just as we begin to wind this
- 34:57down. You mentioned a procedure, an intervention for treatment of hypertension
- 35:02that you have started to pioneer. Can you tell us a little bit about that?
- 35:06Yeah, absolutely. So, you know, blood pressure is a big problem,
- 35:09as we've learned from our discussion.
- 35:11And so we've been looking for ways, you know, different ways,
- 35:15different tools to try to help us managing.
- 35:18And so one of those that came up actually around 2010 was this idea of renal
- 35:23denervation, which is a mouthful, so you can just go ahead and call it RDM.
- 35:28And the idea was, well, we all know that the kidneys, you know,
- 35:32and their interaction are really the command center for blood pressure in the
- 35:35body and interacting with the central nervous system in the heart.
- 35:39And so the kidneys have efferent and afferent nerves going to and from,
- 35:44and they travel in the fat that surrounds the renal arteries that are bringing blood to the kidneys.
- 35:50And so the idea said, well, if we could do something to kind of disrupt that
- 35:54efferent and afferent nerves without damaging the blood vessel,
- 35:58could we have some effect on sympathetic tone? Could we decrease sympathetic
- 36:01tone and improve blood pressure.
- 36:04So they came up with a couple ideas of how to do that, one of which is using
- 36:08radiofrequency waves and the other being ultrasound to try to deliver therapy
- 36:12to those nerves and see what happens. So in around 2010.
- 36:17They did the initial trial, Simplicity 1, and they treated a whole bunch of
- 36:21patients who had resistant hypertension with this, and they got incredible results.
- 36:24These patients had 20 to 30 millimeter reduction in blood pressure.
- 36:28They said, wow, that's great.
- 36:30Let's do another one. So they did Simplicity 2. Same thing happened.
- 36:33They said, well, this looks extremely promising.
- 36:36Let's do a real trial. And so Simplicity 3 came out in about 2012.
- 36:40And in this arm, they did the most important thing that you do when you do a
- 36:43treatment like this with the procedure is you include a sham arm.
- 36:48So patients with resistant hypertension are going to come in.
- 36:51Some of them are going to get the procedure and some of them are going to think
- 36:54they got the procedure, but they didn't get it because you need to rule out
- 36:57that placebo effect and the other confounding factors, which play a huge role.
- 37:01And when they ran the results on that, the difference in blood pressure that
- 37:05they got from it came out as not significant.
- 37:08Everybody was so disappointed and surprised. And in the treatment arm,
- 37:12they did actually have a 14-point reduction in blood pressure.
- 37:15The problem was that the sham arm had an 11-point reduction in blood pressure,
- 37:19so the difference between the two was not significant.
- 37:22But that trial had a lot of problems. There were technical problems.
- 37:26The technology that they used was old. The catheter that they used had only
- 37:31a single emitter on the end of it,
- 37:33and it was a straight catheter, so it just sat kind of in the middle of the
- 37:36vessel and was not making contact with the wall of the vessel close to where those nerves are.
- 37:42Most of the people who did the procedures, many of them, it was the only case they ever did.
- 37:48There was a lot of changes in blood pressure medications in the patients after
- 37:53the procedure was done, which can, for obvious reasons, confound lots of things.
- 37:57And so in around 2020, the idea came, why don't we revisit this?
- 38:02They revamped the technology and they said, let's look at this again. And so.
- 38:06They created a new catheter called a spiral catheter.
- 38:10So now the catheter goes into the renal arteries over a wire.
- 38:14And when you pull the wire back, the catheter opens up into a spiral form,
- 38:19having four emitters on it, making good contact with the wall of the vessel
- 38:22and hopefully getting better penetration of the treatment to where you're trying to get it to.
- 38:28And we learned that these nerves don't just travel in the main renal artery.
- 38:32They travel in its branches too. And so we should be treating also the main
- 38:36branches of that artery.
- 38:38And so now any vessel, any of the branches that are over three millimeters in
- 38:42diameter that are outside of the renal parenchyma, we will treat.
- 38:46And so they did it again, and they did the spiral hypertension off medication
- 38:51and on medication trial. So they treated patients with hypertension who were
- 38:54on no meds and found a statistically significant reduction in blood pressure.
- 38:59And then they did it. Well, what if they're on their meds? They did it there
- 39:02and found about the same thing.
- 39:03The ultrasound technology, they also looked at in the RADIANCE trials, similar outcomes.
- 39:08And what they found was about a five to nine point reduction in systolic blood
- 39:13pressure at the one year mark, which again, doesn't sound like a lot,
- 39:18but as we talked about earlier, that even that makes a big difference.
- 39:21That's super exciting. I wanted to circle back for just a minute here on the
- 39:27front of like, you know, we're all in this together treating our patients and
- 39:32kind of get your impression on how
- 39:36primary care and cardiology can really work together in managing.
- 39:40Our patients with hypertension.
- 39:43Sometimes I see like there might be a little concern about stepping on each
- 39:47other's toes rather than being like, I'm seeing this patient and their blood
- 39:52pressure is consistently elevated.
- 39:54I'm going to make that adjustment in the medication versus go see cardiology
- 39:59and make that adjustment or cardiology seeing that I'm prescribing it and cardiology
- 40:04saying your blood pressure is a little high.
- 40:07Maybe you want to talk to your primary care about it.
- 40:11I'm wondering if you see that or if you have thoughts on what an approach might
- 40:16be where we could really work together and be more efficient in that way in
- 40:23treating blood pressure?
- 40:24Yeah, that's such a great question and so common.
- 40:27So, you know, from the inpatient side of things, as an interventional cardiologist,
- 40:32I definitely will do that.
- 40:33If a patient comes in for heart catheterization and, you know,
- 40:36I notice that their blood pressure is high, I'm going to be not inclined to
- 40:39make any changes because I
- 40:40just met you for one day, and I don't want too many cooks in the kitchen.
- 40:43It's better if, you know, the person who knows you best, who's been following
- 40:47you for a long time is in charge of that. So definitely that sort of mindset.
- 40:51I think a team-based approach to managing these patients is going to be best for everyone. Right?
- 40:58So how to achieve that is hard. One, you know, example of a good way that's
- 41:06working towards accomplishing that goal is the establishment of.
- 41:11Hypertension clinics and resistant hypertension clinics, which a lot of places
- 41:14now have across the country.
- 41:16And they're done in lots of different ways, you know, in lots of places.
- 41:19These are places that are actually kind of run by nephrology and cardiology
- 41:23is involved, especially if there's a proceduralist who, you know, will fix,
- 41:28you know, or do renal denervation or fix, you know, renal artery blockages or
- 41:32fibromuscular dysplasia.
- 41:33But there's this sort of one central place where everyone's,
- 41:36you know, together in one unit and communicating with each other.
- 41:39I think establishing something like that in whatever fashion works best in our,
- 41:45unique situation here in Maine could be a great goal for the future.
- 41:50But in terms of just from the day-to-day now and how we do things.
- 41:54It's a little different for me. If I'm seeing someone in the office from a cardiology
- 41:59standpoint and they're being sent to me for hypertension.
- 42:03I'm going to have no problem managing their hypertension.
- 42:07That's why they're here. That's the help I'm being asked for.
- 42:10I'm going to do, you know, what I think and then communicate that back,
- 42:14obviously, to the referring provider to let them know, you know,
- 42:17so that we stay, you know, in touch with each other.
- 42:20But it'll definitely be the situation that they're not there for that.
- 42:23They're there for chest pain, you know, and they're working them up for angina
- 42:27or they're there for, you know, a host of other reasons. And they just happen
- 42:30to have high blood pressure. That's a little more tricky.
- 42:34And so I think it's probably going to be pretty hard, you know,
- 42:38because it's not like we're going to be able in our busy days to just call each
- 42:42other and say, hey, are you okay if I go ahead and change this medication, you know?
- 42:46I think, you know, from my standpoint now, my approach to it is if they're seeing
- 42:50me for hypertension, I'm going to manage their hypertension.
- 42:52If they're seeing me for something else and their blood pressure is a little
- 42:56bit elevated, I'm probably not going to do anything about it specifically that
- 42:59day, but I'll make sure I communicate that information back to who's taking
- 43:03care of them. and then primary care setting.
- 43:05If it's very high, and certainly if I've gotten data from this patient from
- 43:09home blood pressure monitoring, that it's more in that stage two realm or higher,
- 43:13I will be more inclined to do something and then obviously communicate that back to primary care.
- 43:19And I think, you know, unfortunately, we do the best we can.
- 43:25But I think our goal in the future would be to find a way in terms of how we
- 43:30can, you know, develop a more formalized team-based, maybe it's a resistant
- 43:35hypertension clinic, or maybe it's something else that's going to work better for us.
- 43:38But, you know, a way that we can do that would be a great goal,
- 43:42I think, for us going forward.
- 43:45I appreciate that. I think, you know, like you said, we don't have the opportunities
- 43:49for the spontaneous, you know, connection.
- 43:52We don't see each other in the hallways like we used to.
- 43:56So conversations like today at this podcast, I think, go a long way.
- 44:01And I so appreciate your time and your expertise. I have learned a ton.
- 44:05I feel encouraged in my ability to manage my patients. And I have notes scratched
- 44:10all over my papers here at my desk. So thank you so much for taking the time
- 44:15to explore this topic with us.
- 44:17Thank you for having me. And for everyone out there who's listening,
- 44:20I'm very approachable. I am happy to help.
- 44:23You can email me at Christopher.Tui at MaineHealth.org, whatever you want.
- 44:27If I can help you answer some questions or help guide you in any way,
- 44:31please feel free to reach out.
- 44:33Yeah, absolutely. Thank you. I agree. It's been a great learning experience. Thank you.
- 44:42Thanks for listening to Curbside Consult. To continue the conversation,
- 44:46please visit the MaineHealth ACO's LinkedIn page at linkedin forward slash company forward slash mhaco.
- 44:55We welcome your reactions, thoughts, and suggestions for what specialties to
- 44:59cover in the months to come. See you next time. See you next time.